Advertisement

The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient

  • Hiroji IwataEmail author
  • Shigehira Saji
  • Masahiko Ikeda
  • Masashi Inokuchi
  • Takayoshi Uematsu
  • Tatsuya Toyama
  • Rie Horii
  • Chikako Yamauchi
Special Article
  • 52 Downloads

Abstract

The Breast Cancer Clinical Practice Guidelines, 2018 edition, written in Japanese and organized by the Japanese Breast Cancer Society, were published in Japanese in May 2018. The process of making these guidelines, as well as the content, was largely changed and compared with previous editions. The concept of these guidelines is to act as a support tool for shared decision making between doctor and patient. The procedure of creating the guidelines referred to Minds Handbook for Clinical Practice Guideline Development 2014. This guideline, written in Japanese, consists of two booklets: (1) the epidemiology and diagnosis booklet covering screening, radiological, and pathological diagnosis and (2) the treatment booklet covering surgical therapy, radiation therapy, and systemic therapy. This review article consists of five parts, including the history of the Breast Cancer Clinical Practice Guidelines, the concept, process, content, and recommendation grade. I believe this brief summary concerning the Breast Cancer Clinical Practice Guidelines 2018 edition in English will be helpful for both Japanese and foreign investigators.

Keywords

Guideline Breast cancer Japan 

Notes

Acknowledgements

We express our heartfelt gratitude to Fujimi Kawai of The Japan Medical Library Association and Prof. Masahiro Yoshida of International University of Health and Welfare, and Japan Council for Quality Health Care who provided extensive support and teach us fundamental advices. We thank Mrs. Hitomi Sasaki and Kazuyo Uno of Kanehara Publishing Co., Ltd for your special support. The Japanese Breast Cancer Society Clinical Practice Guidelines which is described in this review manuscript was made according to the fund from Japanese Breast Cancer Society.

Compliance with ethical standards

Conflict of interest

Hiroji Iwata received research funding from Chugai, Novartis, MSD, and Lilly and honoraria from Chugai, AstraZeneca, and Daiichi Sankyo and serves as an advisory board to Daiichi Sankyo, Chugai, Lilly, Kyowa Hakko Kirin, Pfizer, Novartis, and AstraZeneca. Shigehira Saji received research funding from Chugai, AstraZeneca, Eisai, Takeda, Novartis, Taiho, Nihon Kayaku, and Ono; honoraria from Chugai, AstraZeneca, Eisai, Takeda, Novartis, Taiho, Nihon Kayaku, Kyowa Kirin, Pfizer, and Daiichi-Sankyo and serves as an advisory board to Chugai, Kyowa Kirin, and Novartis. Masahiko Ikeda received research funding from Hisamitsu and honoraria from Chugai, Daiichi Sankyo, Kyowa Hakko Kirin, and Pfizer. Tatsuya Toyama received research funding from Chugai, AstraZeneca, Eisai, and Novartis and honoraria from Chugai, AstraZeneca, Eisai, Novartis, Lilly, Kyowa Kirin, Taiho, Daiichi-Sankyo, Takeda, Nihon Kayaku, and Pfizer. Rie Horii received honoraria from Chugai, Roche Diagnostics, AstraZeneca, Taiho, Takeda, Pfizer, and Eisai and serves as advisory board to Chugai. Masashi Inokuchi, Takayoshi Uematsu, and Chikako Yamauchi have no conflicts of interest.

Human participants and animals participant right statement

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Mukai H, Noguchi S, Akiyama F, et al. 2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission. Breast Cancer. 2015;22:1–4.CrossRefGoogle Scholar
  2. 2.
    Morizane T, Yoshida M, Kojimahara N. Minds handbook for clinical practice guideline development. Tokyo: Igaku Shoin; 2014.Google Scholar
  3. 3.
    Fukui T, Yamaguchi N, editors. Minds Guideline Center, Japan Council for Quality Health Care; 2015.Google Scholar

Copyright information

© The Japanese Breast Cancer Society 2019

Authors and Affiliations

  1. 1.Department of Breast OncologyAichi Cancer Center HospitalNagoyaJapan
  2. 2.Department of Medical OncologyFukushima Medical UniversityFukushimaJapan
  3. 3.Department of Breast and Thyroid SurgeryFukuyama City HospitalFukuyamaJapan
  4. 4.Department of Breast Endocrine SurgeryKanazawa Medical UniversityIshikawaJapan
  5. 5.Department of Breast Imaging and Breast Intervention RadiologyShizuoka Cancer CenterShizuokaJapan
  6. 6.Department of Breast SurgeryNagoya City University Graduate School of Medical SciencesNagoyaJapan
  7. 7.Department of PathologySaitama Cancer CenterInaJapan
  8. 8.Department of Radiation OncologyShiga General HospitalMoriyamaJapan

Personalised recommendations